30 DERMATOLOGY

We are advancing research using 30Technology™ to repair skin and provide potent anti-microbial activity, with the potential to enhance the local effects of systemic treatment and several dermatological conditions.

RESEARCH PRIORITIES

ACNE

Acne vulgaris, commonly caused by excessive growth of the bacteria Propionibacterium acnes, is one of the top ten most prevalent diseases worldwide, affecting more than 630 million people and can lead to permanent scarring.

FUNGAL NAIL INFECTIONS (onychomycosis)

One of the hardest to treat superficial fungal infections, onychomycosis is a common dermatological condition affecting up to 26% people worldwide with effective treatment taking up to 12 months.

ATOPIC ECZEMA

Atopic dermatitis is the most common form of eczema, a long- term skin disease, particularly prevalent in children, affecting 15-20% of children worldwide.

PSORIASIS

Psoriasis is estimated to affect 2–4% of the population of the western world including 6.7 million Americans. Psoriasis can have an extremely negative effect on Quality of Life.

30 TECHNOLOGY is developing and defining new models of care to treat many serious medical conditions by enhancing the body’s healing and defence mechanisms.

30 TECHNOLOGY Therapeutic Nitric Oxide